100
Participants
Start Date
June 1, 2023
Primary Completion Date
November 30, 2025
Study Completion Date
December 31, 2025
Polysomnography
Each of the patients will undergo polysomnography
Blood dopamine level measurement
In each of the patients blood dopamine level will be measured
Genetical test
Each of the patients will undergo genetical test focusing on selected single nucleotide polymorphisms within genes regulating the concentration of dopamine - the gene responsible for production of the enzyme catechol-O-methyltransferase (COMT) - rs4680 and rs6269 and genes encoding receptors dopamine (DRD1 - rs686, rs5327 and DRD2 - rs1800497).
Wroclaw Medical Uniwesity, Wroclaw
Wroclaw Medical University
OTHER